Browse
By class.
Curated category hubs — the natural starting points if you're exploring a specific kind of compound. Each lists every profile we cover in the class, the evidence spread, and a short orientation read.
-
13 compounds
GLP-1 & weight loss
Semaglutide, tirzepatide, retatrutide, and the rest of the most-hyped corner of medicine.
Open → -
7 compounds
SARMs
Selective androgen receptor modulators — RAD-140, ostarine, LGD-4033, and the rest of the class.
Open → -
14 compounds
Steroids & PEDs
Anabolic steroids and the surrounding cycle support — the FDA-approved, the historical, and the gray-market.
Open → -
8 compounds
GH secretagogues
Sermorelin, tesamorelin, ipamorelin, CJC-1295, MK-677 — peptides that signal for your own GH.
Open → -
3 compounds
Healing peptides
BPC-157, TB-500, and the gap between online hype and human evidence.
Open → -
4 compounds
Melanocortins
PT-141, melanotan, afamelanotide, setmelanotide — approved drugs and gray-market peptides on the same receptors.
Open → -
4 compounds
Nootropic peptides
Selank, semax, cerebrolysin, dihexa — mostly Eastern European clinical research.
Open → -
4 compounds
SERMs
Tamoxifen, clomiphene, enclomiphene, raloxifene — the most heavily-evidenced class in the toolbox.
Open → -
3 compounds
Aromatase inhibitors
Anastrozole, exemestane, letrozole — approved breast cancer drugs widely repurposed for estrogen control.
Open → -
3 compounds
Cosmetic peptides
Argireline, GHK-Cu, snap-8 — the small studies behind the big skincare claims.
Open → -
3 compounds
Mitochondrial peptides
SS-31, MOTS-c, humanin — interesting mechanism, mostly animal-stage evidence.
Open → -
Topical
Women & peptides
Studies, dosing differences, and safety signals specific to women.
Open →
Or browse the full Ledger of all 100 compounds in one searchable table.